Company Comparison
Tessera Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tessera Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | Lagos, Nigeria |
| Founded | 2018 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series B | Series B |
| Total Funding | $300M | $45M |
| Valuation | — | — |
What They Build
Tessera Therapeutics
Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Tessera Therapeutics
Sector Overlap
Both Tessera Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.